← back to search

Jing Zhao

Tianjin University of Traditional Chinese Medicine · CN
Area of research
Cardiology and Cardiovascular Medicine · Molecular Biology
Research interest
Research interests include Cardiac Fibrosis and Remodeling, Mitochondrial Function and Pathology, MicroRNA in disease regulation, and Nerve injury and regeneration.
h-index
19
citations
1,078
works
55
NIH funding
primary concept
email

Recent publications

Rhynchophylline Regulates Calcium Homeostasis by Antagonizing Ryanodine Receptor 2 Phosphorylation to Improve Diabetic Cardiomyopathy
Frontiers in Pharmacology 2022cited by 23position: middledoi
7,8-Dihydroxyflavone alleviates cardiac fibrosis by restoring circadian signals via downregulating Bmal1/Akt pathway
European Journal of Pharmacology 2022cited by 23position: lastdoi
Small-molecule 7,8-dihydroxyflavone counteracts compensated and decompensated cardiac hypertrophy via AMPK activation.
PubMed 2022cited by 11position: lastdoi
Gap between risk factors and prevention strategies? A nationwide survey of fall prevention among medical and surgical patients
Journal of Advanced Nursing 2022cited by 7position: middledoi
The Emerging Role of BDNF/TrkB Signaling in Cardiovascular Diseases
Life 2021cited by 70position: middledoi
Anthelmintic niclosamide attenuates pressure-overload induced heart failure in mice
European Journal of Pharmacology 2021cited by 17position: middledoi
Paeonol alleviates lipopolysaccharide‑induced hepatocytes injury through alteration of mitochondrial function and NF‑κB translocation
Molecular Medicine Reports 2021cited by 16position: lastdoi
The regulatory role of the BDNF/TrkB pathway in organ and tissue fibrosis.
PubMed 2021cited by 14position: lastdoi
7,8-Dihydroxyflavone suppresses proliferation and induces apoptosis of human osteosarcoma cells
Acta Biochimica et Biophysica Sinica 2021cited by 8position: firstdoi
miR-9-5p Promotes β-Catenin-Activated Epithelial-To-Mesenchymal Transition of Triple-Negative Breast Cancer Via Targeting LZTS2
Research Square 2020cited by 0position: middledoi
The different response of cardiomyocytes and cardiac fibroblasts to mitochondria inhibition and the underlying role of STAT3
Basic Research in Cardiology 2019cited by 52position: firstdoi
Brain-derived neurotrophic factor mimetic, 7,8-dihydroxyflavone, protects against myocardial ischemia by rebalancing optic atrophy 1 processing
Free Radical Biology and Medicine 2019cited by 46position: middledoi
Activation of cardiac TrkB receptor by its small molecular agonist 7,8-dihydroxyflavone inhibits doxorubicin-induced cardiotoxicity via enhancing mitochondrial oxidative phosphorylation
Free Radical Biology and Medicine 2018cited by 49position: firstdoi
Characterizations of mitochondrial uncoupling induced by chemical mitochondrial uncouplers in cardiomyocytes
Free Radical Biology and Medicine 2018cited by 47position: middledoi
BDNF-mediates Down-regulation of MicroRNA-195 Inhibits Ischemic Cardiac Apoptosis in Rats
International Journal of Biological Sciences 2016cited by 72position: middledoi
Brain‐derived neurotrophic factor attenuates doxorubicin‐induced cardiac dysfunction through activating Akt signalling in rats
Journal of Cellular and Molecular Medicine 2016cited by 46position: middledoi
Brain-Derived Neurotrophic Factor Regulates TRPC3/6 Channels and Protects Against Myocardial Infarction in Rodents
International Journal of Biological Sciences 2015cited by 76position: middledoi
MicroRNAs: New players in pharmacotherapy for ischemic heart diseases?
International Journal of Cardiology 2015cited by 0position: middledoi
Krüppel-like Factor 8 Ameliorates Alzheimer's Disease by Activating β-Catenin
Journal of Molecular Neuroscience 2013cited by 21position: middledoi
Novel Insights into the Pervasive Role of M3 Muscarinic Receptor in Cardiac Diseases
Current Drug Targets 2013cited by 17position: middledoi
TRPC6, a potential novel target for enhancing cardiac repair of bone marrow mesenchymal stem cells
International Journal of Cardiology 2012cited by 2position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Pengzhou Hang · Harbin Medical University13 papers (2012–2022)Zhimin Du · The First Affiliated Hospital, Sun Yat-sen University10 papers (2013–2022)Peifeng Li · University of Illinois Chicago6 papers (2019–2022)De‐Li Dong · China Pharmaceutical University3 papers (2018–2021) · 3 papers (2021–2021) · 3 papers (2021–2021)Minghui Ma · Harbin Medical University3 papers (2018–2021)Nan Hu · Hubei University of Medicine3 papers (2018–2021)Jin‐Lai Gao · Harbin Medical University3 papers (2018–2021)Yao Fu · Qingdao University3 papers (2018–2021)Chuan Sun · Harbin Medical University2 papers (2015–2016)Yue Li · Emory University2 papers (2012–2015)Fengfeng Li · Harbin Medical University2 papers (2022–2022)Haibin Zhu · Nanchang University2 papers (2018–2019)Xuan Peng · Chongqing Normal University2 papers (2018–2019)Yang Pan · University of Maryland, College Park2 papers (2018–2022)Man Jiang · Harbin Medical University2 papers (2019–2021)Jun-Xue Zhu · Harbin Medical University2 papers (2018–2019)Hong-Yu Ji · Harbin Medical University2 papers (2022–2022)Jing Guo · Kunming University of Science and Technology2 papers (2015–2016)